Literature DB >> 24832632

From SYMPLICITY HTN-3 to the renal denervation global registry: where do we stand and where should we go?

Atul Pathak1, Sebastian Ewen, Jean Fajadet, Benjamin Honton, Felix Mahfoud, Jean Marco, Markus Schlaich, Roland Schmieder, Konstantinos Tsioufis, Christian Ukena, Thomas Zeller.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24832632     DOI： 10.4244/EIJV10I1A4

Source DB:  PubMed          Journal:  EuroIntervention        ISSN： 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  7 in total

Review 1.  Hypertension: history and development of established and novel treatments.

Authors:  Milan Wolf; Sebastian Ewen; Felix Mahfoud; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-06-27       Impact factor: 5.460

2.  Renal denervation--a valid treatment option despite SYMPLICITY HTN-3.

Authors:  Roland E Schmieder
Journal:  Nat Rev Cardiol       Date:  2014-09-30       Impact factor: 32.419

Review 3.  Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence.

Authors:  Alexandre Persu; Fadl Elmula M Fadl Elmula; Yu Jin; Ingrid Os; Sverre E Kjeldsen; Jan A Staessen
Journal:  Eur Cardiol       Date:  2014-12

Review 4.  Renal Denervation: Is It Ready for Prime Time?

Authors:  Lucas Lauder; Milan A Wolf; Sean S Scholz; Mathias Hohl; Felix Mahfoud; Michael Böhm
Journal:  Curr Cardiol Rep       Date:  2019-07-05       Impact factor: 2.931

5.  Renal Denervation in Patients With Uncontrolled Hypertension and Confirmed Adherence to Antihypertensive Medications.

Authors:  Mohammed Awais Hameed; Mark Pucci; Una Martin; Richard Watkin; Sagar Doshi; Jonathan Freedman; Peter Riley; Jonathan Townend; Paul Crowe; Graham Lipkin; Indranil Dasgupta
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-10-05       Impact factor: 3.738

Review 6.  Where and when device therapy may be useful in the management of drug-resistant hypertension.

Authors:  Herbert D Aronow; Jun Li; Sahil A Parikh
Journal:  Curr Cardiol Rep       Date:  2014-11       Impact factor: 2.931

Review 7.  Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension.

Authors:  Fadl Elmula M Fadl Elmula; Anne C Larstorp; Sverre E Kjeldsen; Alexandre Persu; Yu Jin; Jan A Staessen
Journal:  Front Physiol       Date:  2015-02-09       Impact factor: 4.566
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.